|Gender as a modifying factor influencing myotonic dystrophy type 1 phenotype severity and mortality: a nationwide multiple databases cross-sectional observational study|
C Dogan, M De Antonio, D Hamroun, H Varet, M Fabbro, F Rougier, ...
PloS one 11 (2), e0148264, 2016
|Agreement between dementia patient report and proxy reports using the Nottingham Health Profile|
F Boyer, JL Novella, I Morrone, D Jolly, F Blanchard
International Journal of Geriatric Psychiatry 19 (11), 1026-1034, 2004
|Factors relating to carer burden for families of persons with muscular dystrophy|
F Boyer, M Drame, I Morrone, JL Novella
Journal of Rehabilitation Medicine 38 (5), 309-315, 2006
|Potentially inappropriate use of psychotropic medications in hospitalized elderly patients in France|
M Prudent, M Drame, D Jolly, T Trenque, R Parjoie, R Mahmoudi, ...
Drugs & aging 25 (11), 933-946, 2008
|Health related quality of life in people with hereditary neuromuscular diseases: an investigation of test–retest agreement with comparison between two generic questionnaires …|
F Boyer, I Morrone, I Laffont, O Dizien, JC Etienne, JL Novella
Neuromuscular Disorders 16 (2), 99-106, 2006
|Effort training in Parkinson's disease: a systematic review|
L Tambosco, L Percebois-Macadré, A Rapin, J Nicomette-Bardel, ...
Annals of physical and rehabilitation medicine 57 (2), 79-104, 2014
|Post-polio syndrome and rehabilitation|
V Tiffreau, A Rapin, R Serafi, L Percebois-Macadré, C Supper, D Jolly, ...
Annals of physical and rehabilitation medicine 53 (1), 42-50, 2010
|Methodological issues regarding power of classical test theory (CTT) and item response theory (IRT)-based approaches for the comparison of patient-reported outcomes in two …|
V Sébille, JB Hardouin, T Le Néel, G Kubis, F Boyer, F Guillemin, ...
BMC Medical Research Methodology 10 (1), 24, 2010
|Efficacy and safety of abobotulinumtoxinA in spastic lower limb: Randomized trial and extension|
JM Gracies, A Esquenazi, A Brashear, M Banach, S Kocer, R Jech, ...
Neurology 89 (22), 2245-2253, 2017
|Post-polio syndrome: Pathophysiological hypotheses, diagnosis criteria, medication therapeutics|
FC Boyer, V Tiffreau, A Rapin, I Laffont, L Percebois-Macadré, C Supper, ...
Annals of physical and rehabilitation medicine 53 (1), 34-41, 2010
|Evaluation of a stair-climbing power wheelchair in 25 people with tetraplegia|
I Laffont, B Guillon, C Fermanian, S Pouillot, A Even-Schneider, F Boyer, ...
Archives of physical medicine and rehabilitation 89 (10), 1958-1964, 2008
|Evaluation of a graphic interface to control a robotic grasping arm: a multicenter study|
I Laffont, N Biard, G Chalubert, L Delahoche, B Marhic, FC Boyer, ...
Archives of physical medicine and rehabilitation 90 (10), 1740-1748, 2009
|Effects of repeated abobotulinumtoxinA injections in upper limb spasticity|
JM Gracies, M O'Dell, M Vecchio, P Hedera, S Kocer, M Rudzinska‐Bar, ...
Muscle & nerve 57 (2), 245-254, 2018
|Predictors of institution admission in the year following acute hospitalisation of elderly people|
M Dramé, F Fierobe, PO Lang, D Jolly, F Boyer, R Mahmoudi, D Somme, ...
The journal of nutrition, health & aging 15 (5), 399-403, 2011
|Vestibular rehabilitation therapy|
FC Boyer, L Percebois-Macadré, E Regrain, M Lévêque, R Taïar, ...
Neurophysiologie Clinique/Clinical Neurophysiology 38 (6), 479-487, 2008
|Health status in patients with Alzheimer’s disease: an investigation of inter-rater agreement|
JL Novella, F Boyer, C Jochum, N Jovenin, I Morrone, D Jolly, S Bakchine, ...
Quality of Life Research 15 (5), 811-819, 2006
|Executive functions of children with developmental dyspraxia: Assessment combining neuropsychological and ecological tests|
M Toussaint-Thorin, F Marchal, O Benkhaled, P Pradat-Diehl, FC Boyer, ...
Annals of Physical and Rehabilitation Medicine 56 (4), 268-287, 2013
|Predictors of rapid cognitive decline among demented subjects aged 75 or more:(‘Sujet Agé Fragile—Evaluation et Suivi’Cohort—SAFES)|
S Viatonou, M Dramé, D Jolly, I Morrone, PO Lang, T Voisin, FC Boyer, ...
International Journal of Geriatric Psychiatry: A journal of the psychiatry …, 2009
|Effect of enzyme replacement therapy with alglucosidase alfa (Myozyme®) in 12 patients with advanced late-onset Pompe disease|
C Papadopoulos, D Orlikowski, H Prigent, A Lacour, C Tard, A Furby, ...
Molecular genetics and metabolism 122 (1-2), 80-85, 2017
|Family caregivers and hereditary muscular disorders: association between burden, quality of life and mental health|
F Boyer, JL Novella, JM Coulon, F Delmer, I Morrone, N Lemoussu, ...
Annales de readaptation et de medecine physique: revue scientifique de la …, 2006